Poxel Presents Imeglimin Japanese Phase 1 Results and Mechanistic Data at the 9th Scientific Meeting of the Asian Association for the Study of Diabetes in Japan May 22, 2017
Poxel Announces Positive Top Line Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes May 4, 2017
Poxel to Present New Imeglimin Data at the 9th Scientific Meeting of the Asian Association for the Study of Diabetes in Japan Apr 20, 2017
Poxel Announces Appointment of Christophe Arbet-Engels, MD, PhD, MBA, as Chief Medical Officer and EVP Late Development & Medical Affairs, Based in Boston Mar 7, 2017
